| Bid Price | High Price | ||
|---|---|---|---|
| Ask Price | Low Price | ||
| Open Price | Spread | ||
| Prev Close | Volume |
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Feb 19, 2019 | 0.81 | 0.81 | 0.78 | 0.80 | 317,139 |
| Feb 18, 2019 | 0.79 | 0.82 | 0.79 | 0.80 | 2,368,459 |
| Feb 15, 2019 | 0.82 | 0.83 | 0.79 | 0.80 | 7,334,221 |
| Feb 14, 2019 | 0.78 | 0.82 | 0.77 | 0.80 | 5,627,232 |
| Feb 13, 2019 | 0.84 | 0.88 | 0.77 | 0.80 | 4,125,776 |
| Name | ValiRx | Epic | VAL |
|---|---|---|---|
| ISIN | GB00BWWYSP41 | Currency | GBX |
| Type | Equity | Trading Segment | ASX1 |
| Record Status | Active | Trading Status | Regular Trading |
| Industry | Health Care | Sector | Pharmaceuticals & Biotechnology |
| EMS | 30,000 | Prev Close | 0.80 |
| Shares in Issue (m) | 598.30 | Market Cap (£m) | 4.79 |
| PE Ratio | -0.42 | Div per Share (p) | 0.00 |
| Div Yield | 0.00 | Div Cover | 0.00 |
| EPS | -1.90 | EPS Growth (%) | 77.75 |
| PEG | -0.01 | DPS Growth (%) | n/a |
| ROCE | -112.34 | Net Gearing | 21.94 |
| Quick Ratio | 1.13 | Current Ratio | 1.13 |
| Date | Broker | Recomm. | Price | Old Target | New Target | Notes |
|---|---|---|---|---|---|---|
| 08 Dec | Northland Capital | Corporate | 0.80 | - | - | Reiterates |
| 01 Dec | Northland Capital | Corporate | 0.80 | - | - | Reiterates |
| 29 Nov | Northland Capital | Corporate | 0.80 | - | - | Reiterates |
| 03 Nov | Northland Capital | Corporate | 0.80 | - | - | Reiterates |
| 13 Oct | Northland Capital | Corporate | 0.80 | - | - | Reiterates |
| Date | Director | Type | Volume / Price | Trade Value |
|---|---|---|---|---|
| 15 Mar 2017 | Satu Vainikka | Buy | 400,000 @ 2.50p | £10,000.00 |
| 15 Mar 2017 | George Morris | Buy | 400,000 @ 2.50p | £10,000.00 |
| 15 Mar 2017 | Gerald Desler | Buy | 400,000 @ 2.50p | £10,000.00 |
| 02 Mar 2017 | Satu Vainikka | Placing | 400,000 @ 2.50p | £10,000.00 |
| 02 Mar 2017 | George Morris | Placing | 400,000 @ 2.50p | £10,000.00 |
